Nurix Therapeutics Is A Biopharmaceutical Company Founded In 2009Specializing In Targeted Protein Degradation To Treat Diseases Such As Cancer And Immune Disordersthe Companywhich Was Renamed From Kura Therapeutics In 2012Focuses On Modulating Protein Levels Using E3 Ubiquitin Ligasesthis Innovative Approach Aims To Effectively Degrade Or Stabilize Disease Causing Proteins Nurix Has Developed A Proprietary Drug Discovery Platform That Targets E3 Ligases To Create Small Molecule Degraders And Stabilizersthe Company Is Advancing Its Pipeline In Oncology And Immunologywith Several Candidates Currently In Clinical Trialsnurix Collaborates With Leading Firms Like Gilead Sciencessanofiand Pfizer To Enhance Its Drug Discovery And Development Effortsthe Leadership Team Combines Extensive Academic And Biopharmaceutical Expertisepositioning Nurix As A Key Player In Precision Medicine
No conferences found for this company.
| Company Name | Nurix Therapeutics Inc |
| Country |
United States
|
| Address | 1700 Owens Street Suite 205 San Francisco Ca 94158 |
| Telephone | Login to View |
| Login to View |
